We started off last week with silver, and this week we’ve got another perspective on the white metal, which has grown by leaps and bounds this year, but remains under US$30 per ounce.

I spoke with David Smith of the Morgan Report and Money Metals, who said he sees a bright future for silver, and encouraged investors to be cautious about trading in and out of the market.

In his view, once silver can close above US$30 a couple of times, it will run up quickly, possibly leaving those who aren’t invested without another opportunity to get in. Overall, he emphasized that the current situation is not like silver’s “false bull run” in 2016 — it’s the real deal.

“When this thing really gets underway and decides to challenge the high US$30s and into the US$40s, I don’t think it’s going to take any prisoners” — David Smith, the Morgan Report, Money Metals

I also spoke with Brian Leni of Junior Stock Review about how his portfolio has been doing this year. Describing the current environment as a “stock picker’s market,” he said the last six months have probably been the most profitable he’s seen in his life — he mentioned Abraplata Resource (TSXV:ABRA,OTC Pink:ABBRF) as his first 13 bagger.

Brian also discussed the dichotomy between the ideas he presents to his newsletter audience and the decisions he makes privately, saying that while he’s careful when it comes to recommendations for his followers he allows himself to be somewhat riskier when making his own personal trades.

“I’m much more conservative when it comes to my money and how I present it to my readers … on the other side of things, I do have a more speculative side to myself … and with my own money I’ll take some of those chances and do some shorter-term trades” — Brian Leni, Junior Stock Review

For our Twitter poll this week, we continued last week’s election theme. Normally a presidential election in the US is a fairly big talking point for the gold price, but this year it’s understandably been overshadowed by other factors.

With only about two months left before America goes to the polls, we asked our followers if a Donald Trump victory or a Joe Biden victory would be better for the gold price. By the time the poll closed, a narrow majority said they think a Trump victory would be more beneficial — although some commenters said they don’t think it will make a difference who wins.

We’ll be asking another question on Twitter next week, so make sure to follow us @INN_Resource or follow me @Charlotte_McL to share your thoughts!

In the cannabis space this week, INN’s Bryan Mc Govern had the opportunity to speak with Vic Neufeld, former CEO of Aphria (TSX:APHA,NASDAQ:APHA).

Vic left the major marijuana company in January 2019 citing health concerns, although his departure also came soon after a short seller report questioned Aphria’s Latin American acquisitions.

He’s now re-emerged as a director and advisor at Havn Life Sciences (CSE:HAVN), a new psychedelics company that went public this week. Explaining his interest in psychedelics, Vic cited their potential to help treat mental health issues as a key draw, and noted that research will be key moving forward.

“It’s something that we really need to have a better understanding of — the standardization, the efficacy, the safety (of psychedelics) so researchers … can take it to the next level” — Vic Neufeld, Havn Life Sciences

Vic won’t be involved with Havn’s day-to-day operations, which he said will help him better balance his work and home life. “In simple words, no more heavy lifting for me,” he explained.

Want more YouTube content? Check out our YouTube playlist At Home With INN, which features interviews with experts in the resource space. If there’s someone you’d like to see us interview, please send an email to cmcleod@investingnews.com.

And don’t forget to follow us @INN_Resource for real-time updates! 

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less

For the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, World High Life announces that the Company has 230,119,819 ordinary shares of 1p each in issue (“Ordinary Shares”), each share carrying the right to one vote. The figure of 230,119,819 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules

The Directors of the Company accept responsibility for the contents of this announcement.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces that it has granted an aggregate of 400,000 options at an exercise price of CDN$1.00, exercisable for a period of five years, to directors and officers of the Company. The stock options are being granted pursuant to the terms of the Company’s stock option plan, and are subject to regulatory approval.

About TransCanna Holdings Inc.

Keep reading... Show less

Donation will benefit veteran-focused organizations and nonprofits, including all TruVet Program partners

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a United States -based leading medical cannabis company, announced today a donation for all TruVet Program partners year-to-date in honor of Veterans Day. A total of $15,000 representing a portion of the November proceeds from the Company’s limited-edition Freedom Pre-Roll product, will be shared among program partners, which are veteran-focused organizations andor nonprofits.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannibas, Inc. (“Aurora” or the “Company”) (NYSE:ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.comacb

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less